Atrial‐Specific Drugs:
- 13 December 2004
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 15 (12) , 1451-1452
- https://doi.org/10.1046/j.1540-8167.2004.04569.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- AZD7009:Journal of Cardiovascular Electrophysiology, 2004
- “Early” Class III Drugs for the Treatment of Atrial FibrillationCirculation, 2004
- Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channelsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2004
- Pharmacology of cardiac potassium channelsPublished by Oxford University Press (OUP) ,2004
- Molecular Basis for Kv1.5 Channel BlockJournal of Biological Chemistry, 2004
- Assessing predictors of drug-induced torsade de pointesTrends in Pharmacological Sciences, 2003
- Kv1.5 Is an Important Component of Repolarizing K + Current in Canine Atrial MyocytesCirculation Research, 2003
- Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atriumThe Journal of Physiology, 2000
- Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial FibrillationCirculation, 2000
- Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circulation Research, 1993